| 2026-05-13 |
13G |
XCBE / X3 Acquisition Corp. Ltd.
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G |
WLII / Willow Lane Acquisition Corp. II
|
|
|
1,000,000 |
|
|
|
| 2026-05-13 |
13G |
TRGS / TRG Latin America Acquisitions Corp.
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G |
SUMA / SUMA Acquisition Corporation
|
|
|
1,350,000 |
|
|
|
| 2026-05-13 |
13G |
SVIV / Spring Valley Acquisition Corp. IV
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G |
TMTSU / Spartacus Acquisition Corp. II - Debt/Equity Composite Units
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G |
SAAQ / Space Asset Acquisition Corp.
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G |
SORN / Soren Acquisition Corp.
|
|
|
1,980,000 |
|
|
|
| 2026-05-13 |
13G |
QADRU / QDRO Acquisition Corp. - Debt/Equity Composite Units
|
|
|
1,500,000 |
|
|
|
| 2026-05-13 |
13G |
|
|
|
2,767,441 |
|
|
|
| 2026-05-13 |
13G |
PALO / Paloma Acquisition Corp I
|
|
|
1,350,000 |
|
|
|
| 2026-05-13 |
13G |
IRD / Opus Genetics, Inc.
|
|
|
6,029,775 |
|
|
|
| 2026-05-13 |
13G |
OIM / OneIM Acquisition Corp.
|
|
|
2,250,000 |
|
|
|
| 2026-05-13 |
13G |
MUZE / Muzero Acquisition Corp
|
|
|
1,575,000 |
|
|
|
| 2026-05-13 |
13G |
MLAA / Mountain Lake Acquisition Corp. II
|
|
|
2,100,000 |
|
|
|
| 2026-05-13 |
13G |
MNRO / Monro, Inc.
|
|
1,500,000 |
1,548,270 |
|
|
|
| 2026-05-13 |
13G |
MTAL / Metals Acquisition Corp. II
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G |
MEVO / M Evo Global Acquisition Corp II
|
|
|
2,430,000 |
|
|
|
| 2026-05-13 |
13G |
LEGO / Legato Merger Corp. IV
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G |
KRAQ / KRAKacquisition Corp.
|
|
|
2,475,000 |
|
|
|
| 2026-05-13 |
13G |
KPTI / Karyopharm Therapeutics Inc.
|
|
436,736 |
1,821,736 |
|
|
|
| 2026-05-13 |
13G/A |
WVE / Wave Life Sciences Ltd.
|
|
9,786,061 |
1,000,000 |
|
|
|
| 2026-05-13 |
13G |
IRAB / Iris Acquisition Corp II
|
|
|
1,350,000 |
|
|
|
| 2026-05-13 |
13G |
IEAG / Infinite Eagle Acquisition Corp.
|
|
|
2,250,000 |
|
|
|
| 2026-05-13 |
13G |
IPFXU / Inflection Point Acquisition Corp. VI - Debt/Equity Composite Units
|
|
|
1,500,000 |
|
|
|
| 2026-05-13 |
13G/A |
TERN / Terns Pharmaceuticals, Inc.
|
|
5,550,000 |
2,124,817 |
|
|
|
| 2026-05-13 |
13G/A |
TNGX / Tango Therapeutics, Inc.
|
|
10,607,924 |
12,809,485 |
|
|
|
| 2026-05-13 |
13G |
HCIC / Hennessy Capital Investment Corp. VIII
|
|
|
1,890,000 |
|
|
|
| 2026-05-13 |
13G |
FVAV / Fortress Value Acquisition Corp. V
|
|
|
2,250,000 |
|
|
|
| 2026-05-13 |
13G/A |
RLMD / Relmada Therapeutics, Inc.
|
|
4,270,000 |
4,763,158 |
|
|
|
| 2026-05-13 |
13G/A |
SDRL / Seadrill Limited
|
|
3,138,286 |
2,463,436 |
|
|
|
| 2026-05-13 |
13G/A |
NPB / Northpointe Bancshares, Inc.
|
|
1,794,104 |
2,601,503 |
|
|
|
| 2026-05-13 |
13G |
FBRX / Forte Biosciences, Inc.
|
|
|
950,000 |
|
|
|
| 2026-05-13 |
13G |
FGII / FG Imperii Acquisition Corp.
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G/A |
NBR / Nabors Industries Ltd.
|
|
1,260,000 |
740,000 |
|
|
|
| 2026-05-13 |
13G |
CMII / Columbus Circle Capital Corp II
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G/A |
MNPR / Monopar Therapeutics Inc.
|
|
599,195 |
424,195 |
|
|
|
| 2026-05-13 |
13G |
CAQ / Cambridge Acquisition Corp.
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G/A |
MIST / Milestone Pharmaceuticals Inc.
|
|
8,659,064 |
8,000,000 |
|
|
|
| 2026-05-13 |
13G |
BWIV.U / Blue Water Acquisition Corp. IV - Debt/Equity Composite Units
|
|
|
1,125,000 |
|
|
|
| 2026-05-13 |
13G/A |
MGTX / MeiraGTx Holdings plc
|
|
4,184,578 |
4,000,000 |
|
|
|
| 2026-05-13 |
13G |
BBCQ / Bleichroeder Acquisition Corp. II
|
|
|
2,250,000 |
|
|
|
| 2026-05-13 |
13G/A |
MCB / Metropolitan Bank Holding Corp.
|
|
559,479 |
584,633 |
|
|
|
| 2026-05-13 |
13G |
ACAA / Averin Capital Acquisition Corp.
|
|
|
2,250,000 |
|
|
|
| 2026-05-13 |
13G |
ATRA / Atara Biotherapeutics, Inc.
|
|
|
700,000 |
|
|
|
| 2026-05-13 |
13G/A |
INO / Inovio Pharmaceuticals, Inc.
|
|
5,517,650 |
4,233,529 |
|
|
|
| 2026-05-13 |
13G |
AACI / Armada Acquisition Corp. III
|
|
|
2,025,000 |
|
|
|
| 2026-05-13 |
13G/A |
HRTX / Heron Therapeutics, Inc.
|
|
8,850,000 |
0 |
|
|
|
| 2026-05-13 |
13G/A |
EYPT / EyePoint, Inc.
|
|
4,700,000 |
3,300,000 |
|
|
|
| 2026-05-13 |
13G |
ARCI / Archimedes Tech SPAC Partners III Co.
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G/A |
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
14,614,449 |
22,272,884 |
|
|
|
| 2026-05-13 |
13G |
ALOV / Aldabra 4 Liquidity Opportunity Vehicle, Inc.
|
|
|
1,750,000 |
|
|
|
| 2026-05-13 |
13G/A |
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
10,035,000 |
8,925,010 |
|
|
|
| 2026-05-13 |
13G |
AACO / Abony Acquisition Corp. I
|
|
|
1,800,000 |
|
|
|
| 2026-05-13 |
13G/A |
ADGM / Adagio Medical Holdings, Inc.
|
|
1,058,501 |
1,258,501 |
|
|
|
| 2026-02-12 |
13G |
VHCPU / Vine Hill Capital Investment Corp. II - Debt/Equity Composite Units
|
|
|
1,575,000 |
|
|
|
| 2026-02-12 |
13G |
SBXE / SilverBox Corp V
|
|
|
1,750,000 |
|
|
|
| 2026-02-12 |
13G |
TERN / Terns Pharmaceuticals, Inc.
|
|
|
5,550,000 |
|
|
|
| 2026-02-12 |
13G/A |
PRAX / Praxis Precision Medicines, Inc.
|
|
1,305,175 |
965,313 |
|
|
|
| 2026-02-12 |
13G |
TWLV / Twelve Seas Investment Company III
|
|
|
1,350,000 |
|
|
|
| 2026-02-12 |
13G |
RLMD / Relmada Therapeutics, Inc.
|
|
|
4,270,000 |
|
|
|
| 2026-02-12 |
13G |
SAC / Safeguard Acquisition Corp.
|
|
|
1,800,000 |
|
|
|
| 2026-02-12 |
13G |
TNGX / Tango Therapeutics, Inc.
|
|
2,511,000 |
10,607,924 |
|
|
|
| 2026-02-12 |
13G |
DSACU / Daedalus Special Acquisition Corp. - Debt/Equity Composite Units
|
|
|
1,800,000 |
|
|
|
| 2026-02-12 |
13G |
TRAW / Traws Pharma, Inc.
|
|
330,000 |
730,000 |
|
|
|
| 2026-02-12 |
13G/A |
SLDB / Solid Biosciences Inc.
|
|
4,000,000 |
1,400,000 |
|
|
|
| 2026-02-12 |
13G/A |
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
6,816,828 |
2,777,055 |
|
|
|
| 2026-02-12 |
13G |
CCXIU / Churchill Capital Corp XI - Debt/Equity Composite Units
|
|
|
2,700,000 |
|
|
|
| 2026-02-12 |
13G/A |
ABEO / Abeona Therapeutics Inc.
|
|
5,352,996 |
0 |
|
|
|
| 2026-02-12 |
13G/A |
MNRO / Monro, Inc.
|
|
2,222,000 |
1,500,000 |
|
|
|
| 2026-02-12 |
13G/A |
EYPT / EyePoint, Inc.
|
|
5,559,782 |
4,700,000 |
|
|
|
| 2026-02-12 |
13G/A |
WVE / Wave Life Sciences Ltd.
|
|
15,016,500 |
9,786,061 |
|
|
|
| 2026-02-12 |
13G |
CRAN / Crane Harbor Acquisition Corp. II
|
|
|
2,700,000 |
|
|
|
| 2026-02-12 |
13G |
NBR / Nabors Industries Ltd.
|
|
|
1,260,000 |
|
|
|
| 2026-02-12 |
13G |
MCB / Metropolitan Bank Holding Corp.
|
|
|
559,479 |
|
|
|
| 2026-02-12 |
13G |
LFACU / Leapfrog Acquisition Corporation - Debt/Equity Composite Units
|
|
|
1,125,000 |
|
|
|
| 2026-02-12 |
13G |
LPCVU / Launchpad Cadenza Acquisition Corp I - Debt/Equity Composite Units
|
|
|
1,250,000 |
|
|
|
| 2026-02-12 |
13G |
VACI / Viking Acquisition Corp. I
|
|
|
1,800,000 |
|
|
|
| 2026-02-12 |
13G |
HCACU / Hall Chadwick Acquisition Corp. - Debt/Equity Composite Units
|
|
|
1,620,000 |
|
|
|
| 2026-02-12 |
13G |
TDWD / Tailwind 2.0 Acquisition Corp.
|
|
|
1,350,000 |
|
|
|
| 2026-02-12 |
13G/A |
KPTI / Karyopharm Therapeutics Inc.
|
|
6,551,055 |
436,736 |
|
|
|
| 2026-02-12 |
13G |
DYOR / Insight Digital Partners II
|
|
|
1,350,000 |
|
|
|
| 2026-02-12 |
13G |
GPACU / General Purpose Acquisition Corp. - Debt/Equity Composite Units
|
|
|
1,800,000 |
|
|
|
| 2026-02-12 |
13G |
APXT / Apex Treasury Corporation
|
|
|
2,250,000 |
|
|
|
| 2026-02-12 |
13G |
DNMX / Dynamix Corporation III
|
|
|
1,575,000 |
|
|
|
| 2026-02-12 |
13G |
KBONU / Karbon Capital Partners Corp. - Debt/Equity Composite Units
|
|
|
2,700,000 |
|
|
|
| 2026-02-12 |
13G |
NERV / Minerva Neurosciences, Inc.
|
|
|
2,838,000 |
|
|
|
| 2026-02-12 |
13G |
EVOX / Evolution Global Acquisition Corp
|
|
|
1,890,000 |
|
|
|
| 2026-02-12 |
13G |
AEAQU / Activate Energy Acquisition Corp. - Debt/Equity Composite Units
|
|
|
1,800,000 |
|
|
|
| 2026-02-12 |
13G |
KTTA / Pasithea Therapeutics Corp.
|
|
|
2,329,749 |
|
|
|
| 2026-02-12 |
13G |
BCSS / Bain Capital GSS Investment Corp.
|
|
|
3,000,000 |
|
|
|
| 2026-02-12 |
13G |
ADACU / American Drive Acquisition Company - Debt/Equity Composite Units
|
|
|
1,250,000 |
|
|
|
| 2026-02-12 |
13G |
IGACU / Invest Green Acquisition Corporation - Debt/Equity Composite Units
|
|
|
1,350,000 |
|
|
|
| 2026-02-12 |
13G |
LZM / Lifezone Metals Limited
|
|
|
5,075,122 |
|
|
|
| 2025-11-13 |
13G |
IBIO / iBio, Inc.
|
|
|
2,181,422 |
|
|
|
| 2025-11-13 |
13G |
INO / Inovio Pharmaceuticals, Inc.
|
|
|
5,517,650 |
|
|
|
| 2025-11-13 |
13G/A |
STR / Sitio Royalties Corp.
|
|
6,263,396 |
0 |
|
|
|
| 2025-11-13 |
13G/A |
ETHM / Dynamix Corporation
|
|
1,350,000 |
125,000 |
|
|
|
| 2025-11-13 |
13G |
EQ / Equillium, Inc.
|
|
|
6,012,624 |
|
|
|
| 2025-11-13 |
13G |
MIST / Milestone Pharmaceuticals Inc.
|
|
|
8,659,064 |
|
|
|
| 2025-11-13 |
13G/A |
ABEO / Abeona Therapeutics Inc.
|
|
4,411,572 |
5,352,996 |
|
|
|
| 2025-11-13 |
13G/A |
SLDB / Solid Biosciences Inc.
|
|
6,729,484 |
4,000,000 |
|
|
|
| 2025-11-13 |
13G/A |
SLNO / Soleno Therapeutics, Inc.
|
|
3,575,964 |
1,401,576 |
|
|
|
| 2025-11-13 |
13G/A |
EYPT / EyePoint, Inc.
|
|
6,800,000 |
5,559,782 |
|
|
|
| 2025-11-13 |
13G/A |
TRAW / Traws Pharma, Inc.
|
|
330,000 |
330,000 |
|
|
|
| 2025-11-13 |
13G/A |
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
8,800,000 |
6,816,828 |
|
|
|
| 2025-11-13 |
13G/A |
ACRS / Aclaris Therapeutics, Inc.
|
|
8,201,344 |
5,278,144 |
|
|
|
| 2025-11-13 |
13G/A |
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
8,403,000 |
10,035,000 |
|
|
|
| 2025-11-13 |
13G/A |
MGTX / MeiraGTx Holdings plc
|
|
5,229,099 |
4,184,578 |
|
|
|
| 2025-11-13 |
13G/A |
FULC / Fulcrum Therapeutics, Inc.
|
|
4,589,000 |
2,432,000 |
|
|
|
| 2025-11-13 |
13G |
OTGAU / OTG Acquisition Corp. I - Debt/Equity Composite Units
|
|
|
1,800,000 |
|
|
|
| 2025-11-13 |
13G/A |
ADGM / Adagio Medical Holdings, Inc.
|
|
821,261 |
1,058,501 |
|
|
|
| 2025-11-13 |
13G/A |
BBOT / BridgeBio Oncology Therapeutics, Inc.
|
|
|
1,487,621 |
|
|
|
| 2025-11-13 |
13G |
LATAU / Galata Acquisition Corp. II - Debt/Equity Composite Units
|
|
|
1,350,000 |
|
|
|
| 2025-11-13 |
13G |
TLNC / Talon Capital Corp.
|
|
|
2,025,000 |
|
|
|
| 2025-11-13 |
13G/A |
ZVRA / Zevra Therapeutics, Inc.
|
|
3,650,000 |
2,225,000 |
|
|
|
| 2025-11-13 |
13G |
NPB / Northpointe Bancshares, Inc.
|
|
|
1,794,104 |
|
|
|
| 2025-11-13 |
13G |
HVMC / Highview Merger Corp.
|
|
|
1,800,000 |
|
|
|
| 2025-11-13 |
13G |
MNRO / Monro, Inc.
|
|
|
2,222,000 |
|
|
|
| 2025-11-13 |
13G |
DRUG / Bright Minds Biosciences Inc.
|
|
|
395,743 |
|
|
|
| 2025-11-13 |
13G/A |
TNGX / Tango Therapeutics, Inc.
|
|
5,905,349 |
2,511,000 |
|
|
|
| 2025-11-03 |
13G/A |
PRAX / Praxis Precision Medicines, Inc.
|
|
2,374,085 |
1,305,175 |
|
|
|
| 2025-10-31 |
13D/A |
ETNB / 89bio, Inc.
|
|
9,097,587 |
0 |
|
|
|
| 2025-10-03 |
13D |
ETNB / 89bio, Inc.
|
|
|
9,097,587 |
|
|
|
| 2025-09-02 |
13G/A |
PRAX / Praxis Precision Medicines, Inc.
|
|
1,974,585 |
2,374,085 |
|
|
|
| 2025-08-12 |
13G/A |
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
5,697,605 |
8,800,000 |
|
|
|
| 2025-08-12 |
13G/A |
TCRX / TScan Therapeutics, Inc.
|
|
|
1,350,000 |
|
|
|
| 2025-08-12 |
13G/A |
EYPT / EyePoint, Inc.
|
|
5,750,000 |
6,800,000 |
|
|
|
| 2025-08-12 |
13G |
ADGM / Adagio Medical Holdings, Inc.
|
|
|
821,261 |
|
|
|
| 2025-08-12 |
13G |
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
14,614,449 |
|
|
|
| 2025-08-12 |
13G |
TNGX / Tango Therapeutics, Inc.
|
|
|
5,905,349 |
|
|
|
| 2025-08-12 |
13G/A |
IMUX / Immunic, Inc.
|
|
1,398,600 |
10,479,337 |
|
|
|
| 2025-08-12 |
13G/A |
JANX / Janux Therapeutics, Inc.
|
|
3,061,750 |
2,525,000 |
|
|
|
| 2025-08-12 |
13G/A |
SLNO / Soleno Therapeutics, Inc.
|
|
4,392,696 |
3,575,964 |
|
|
|
| 2025-08-12 |
13G/A |
CABA / Cabaletta Bio, Inc.
|
|
3,634,475 |
9,002,580 |
|
|
|
| 2025-08-12 |
13G/A |
SDRL / Seadrill Limited
|
|
4,200,535 |
3,138,286 |
|
|
|
| 2025-08-12 |
13G/A |
WVE / Wave Life Sciences Ltd.
|
|
12,516,500 |
15,016,500 |
|
|
|
| 2025-08-12 |
13G/A |
ENSC / Ensysce Biosciences, Inc.
|
|
74,711 |
74,711 |
|
|
|
| 2025-08-12 |
13G/A |
PRQR / ProQR Therapeutics N.V.
|
|
8,102,098 |
6,601,938 |
|
|
|
| 2025-08-12 |
13G/A |
PRAX / Praxis Precision Medicines, Inc.
|
|
1,742,758 |
1,974,585 |
|
|
|
| 2025-08-12 |
13G/A |
ZEO / Zeo Energy Corp.
|
|
760,000 |
760,000 |
|
|
|
| 2025-08-12 |
13G/A |
INZY / Inozyme Pharma, Inc.
|
|
|
0 |
|
|
|
| 2025-08-12 |
13G/A |
CDTX / Cidara Therapeutics, Inc.
|
|
990,000 |
1,100,000 |
|
|
|
| 2025-08-12 |
13G/A |
FULC / Fulcrum Therapeutics, Inc.
|
|
3,000,000 |
4,589,000 |
|
|
|
| 2025-08-12 |
13G/A |
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
6,954,000 |
8,403,000 |
|
|
|
| 2025-08-12 |
13G/A |
ALGS / Aligos Therapeutics, Inc.
|
|
325,000 |
210,000 |
|
|
|
| 2025-06-20 |
13D/A |
|
|
|
50,912 |
|
|
|
| 2025-05-12 |
13G/A |
PRQR / ProQR Therapeutics N.V.
|
|
9,602,280 |
8,102,098 |
|
|
|
| 2025-05-12 |
13G/A |
ACRS / Aclaris Therapeutics, Inc.
|
|
9,627,304 |
8,201,344 |
|
|
|
| 2025-05-12 |
13G/A |
SDRL / Seadrill Limited
|
|
3,429,169 |
4,200,535 |
|
|
|
| 2025-05-12 |
13G/A |
SLNO / Soleno Therapeutics, Inc.
|
|
3,322,146 |
4,392,696 |
|
|
|
| 2025-05-12 |
13G/A |
WVE / Wave Life Sciences Ltd.
|
|
9,703,351 |
12,516,500 |
|
|
|
| 2025-05-12 |
13G |
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
|
5,697,605 |
|
|
|
| 2025-05-12 |
13G |
PRAX / Praxis Precision Medicines, Inc.
|
|
854,083 |
1,742,758 |
|
|
|
| 2025-05-12 |
13G |
CDTX / Cidara Therapeutics, Inc.
|
|
|
990,000 |
|
|
|
| 2025-05-12 |
13G |
SLDB / Solid Biosciences Inc.
|
|
1,754,159 |
6,729,484 |
|
|
|
| 2025-05-12 |
13G |
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
|
6,954,000 |
|
|
|
| 2025-05-12 |
13G |
ENSC / Ensysce Biosciences, Inc.
|
|
|
74,711 |
|
|
|
| 2025-05-12 |
13G/A |
AEVA / Aeva Technologies, Inc.
|
|
|
1,401,454 |
|
|
|
| 2025-05-12 |
13G |
TRAW / Traws Pharma, Inc.
|
|
|
330,000 |
|
|
|
| 2025-05-12 |
13G/A |
URGN / UroGen Pharma Ltd.
|
|
2,928,086 |
1,277,000 |
|
|
|
| 2025-05-12 |
13G/A |
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
|
8,503,780 |
|
|
|
| 2025-05-12 |
13G/A |
TARA / Protara Therapeutics, Inc.
|
|
2,250,000 |
0 |
|
|
|
| 2025-05-12 |
13G/A |
ABEO / Abeona Therapeutics Inc.
|
|
4,210,429 |
4,411,572 |
|
|
|
| 2025-05-12 |
13G/A |
LXEO / Lexeo Therapeutics, Inc.
|
|
2,209,615 |
237,953 |
|
|
|
| 2025-02-12 |
13G |
PRQR / ProQR Therapeutics N.V.
|
|
|
9,602,280 |
|
|
|
| 2025-02-12 |
13G |
MNPR / Monopar Therapeutics Inc.
|
|
|
599,195 |
|
|
|
| 2025-02-12 |
13G/A |
IMUX / Immunic, Inc.
|
|
5,594,406 |
1,398,600 |
|
|
|
| 2025-02-12 |
13G |
KPTI / Karyopharm Therapeutics Inc.
|
|
|
6,551,055 |
|
|
|
| 2025-02-12 |
13G/A |
ENGN / enGene Therapeutics Inc.
|
|
2,329,768 |
1,528,768 |
|
|
|
| 2025-02-12 |
13G/A |
LXEO / Lexeo Therapeutics, Inc.
|
|
2,597,736 |
2,209,615 |
|
|
|
| 2025-02-12 |
13G/A |
EYPT / EyePoint, Inc.
|
|
3,791,420 |
5,750,000 |
|
|
|
| 2025-02-12 |
13G |
ETHM / Dynamix Corporation
|
|
|
1,350,000 |
|
|
|
| 2025-02-12 |
13G/A |
URGN / UroGen Pharma Ltd.
|
|
3,735,741 |
2,928,086 |
|
|
|
| 2025-02-12 |
13G |
ZVRA / Zevra Therapeutics, Inc.
|
|
|
3,650,000 |
|
|
|
| 2025-02-12 |
13G/A |
ALGS / Aligos Therapeutics, Inc.
|
|
218,813 |
325,000 |
|
|
|
| 2025-02-12 |
13G |
ACRS / Aclaris Therapeutics, Inc.
|
|
|
9,627,304 |
|
|
|
| 2025-02-12 |
13G |
SDRL / Seadrill Limited
|
|
|
3,429,169 |
|
|
|
| 2025-02-12 |
13G |
FULC / Fulcrum Therapeutics, Inc.
|
|
|
3,000,000 |
|
|
|
| 2025-02-12 |
13G |
TARA / Protara Therapeutics, Inc.
|
|
|
2,250,000 |
|
|
|
| 2025-02-12 |
13G |
JANX / Janux Therapeutics, Inc.
|
|
|
3,061,750 |
|
|
|
| 2025-02-12 |
13G |
STR / Sitio Royalties Corp.
|
|
|
6,263,396 |
|
|
|
| 2024-11-19 |
13G |
ZEO / Zeo Energy Corp.
|
|
|
760,000 |
|
|
|
| 2024-11-12 |
13G/A |
MGTX / MeiraGTx Holdings plc
|
|
|
5,229,099 |
|
|
|
| 2024-11-12 |
13G/A |
CABA / Cabaletta Bio, Inc.
|
|
|
3,634,475 |
|
|
|
| 2024-11-12 |
13G/A |
RZLT / Rezolute, Inc.
|
|
|
2,842,163 |
|
|
|
| 2024-11-12 |
13G/A |
GHLD / Guild Holdings Company, LLC
|
|
|
597,110 |
|
|
|
| 2024-11-12 |
13G/A |
AMAL / Amalgamated Financial Corp.
|
|
|
716,262 |
|
|
|
| 2024-11-12 |
13G/A |
PWP / Perella Weinberg Partners
|
|
|
1,037,615 |
|
|
|
| 2024-11-12 |
13G/A |
HOWL / Werewolf Therapeutics, Inc.
|
|
|
2,000,594 |
|
|
|
| 2024-11-12 |
13G/A |
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
528,937 |
|
|
|
| 2024-11-12 |
13G/A |
SVRA / Savara Inc.
|
|
|
6,753,701 |
|
|
|
| 2024-11-12 |
13G/A |
ANNX / Annexon, Inc.
|
|
|
3,485,931 |
|
|
|
| 2024-11-12 |
13G/A |
SLDB / Solid Biosciences Inc.
|
|
|
1,754,159 |
|
|
|
| 2024-11-12 |
13G |
HRTX / Heron Therapeutics, Inc.
|
|
|
8,850,000 |
|
|
|
| 2024-11-12 |
13G/A |
AURA / Aura Biosciences, Inc.
|
|
|
4,881,125 |
|
|
|
| 2024-11-12 |
13G/A |
SLNO / Soleno Therapeutics, Inc.
|
|
|
3,322,146 |
|
|
|
| 2024-11-12 |
13G/A |
VINP / Vinci Compass Investments Ltd.
|
|
|
0 |
|
|
|
| 2024-11-12 |
13G/A |
EYPT / EyePoint, Inc.
|
|
5,156,299 |
3,791,420 |
|
|
|
| 2024-11-12 |
13G/A |
WVE / Wave Life Sciences Ltd.
|
|
|
9,703,351 |
|
|
|
| 2024-11-12 |
13G/A |
STRO / Sutro Biopharma, Inc.
|
|
|
2,250,132 |
|
|
|
| 2024-11-12 |
13G/A |
VERU / Veru Inc.
|
|
|
7,861,111 |
|
|
|
| 2024-11-12 |
13G/A |
NKTX / Nkarta, Inc.
|
|
|
3,600,000 |
|
|
|
| 2024-11-12 |
13G/A |
PRAX / Praxis Precision Medicines, Inc.
|
|
|
854,083 |
|
|
|
| 2024-11-12 |
13G/A |
VSTM / Verastem, Inc.
|
|
|
0 |
|
|
|
| 2024-11-12 |
13G |
ENGN / enGene Therapeutics Inc.
|
|
|
2,329,768 |
|
|
|
| 2024-11-12 |
13G |
URGN / UroGen Pharma Ltd.
|
|
|
3,735,741 |
|
|
|
| 2024-11-12 |
13G |
LXEO / Lexeo Therapeutics, Inc.
|
|
|
2,597,736 |
|
|
|
| 2024-11-12 |
13G/A |
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
1,419,792 |
|
|
|
| 2024-11-12 |
13G |
ALGS / Aligos Therapeutics, Inc.
|
|
|
218,813 |
|
|
|
| 2024-11-12 |
13G/A |
MTEM / Molecular Templates, Inc.
|
|
|
0 |
|
|
|
| 2024-11-12 |
13G |
IMUX / Immunic, Inc.
|
|
|
5,594,406 |
|
|
|
| 2024-11-12 |
13G |
TENX / Tenax Therapeutics, Inc.
|
|
|
369,097 |
|
|
|
| 2024-11-04 |
13D |
GLYC / GlycoMimetics, Inc.
|
|
|
5,091,231 |
|
|
|
| 2024-10-22 |
13D/A |
ORKA / Oruka Therapeutics, Inc.
|
|
|
175,000 |
|
|
|
| 2024-06-03 |
13G/A |
ABEO / Abeona Therapeutics Inc.
|
|
|
4,210,429 |
|
|
|
| 2024-05-01 |
13G/A |
EYPT / EyePoint, Inc.
|
|
5,156,299 |
5,156,299 |
|
|
|
| 2024-04-30 |
13G |
EYPT / EyePoint, Inc.
|
|
|
5,156,299 |
|
|
|
| 2024-04-05 |
13D |
ABIO / ARCA biopharma, Inc.
|
|
|
1,200,000 |
|
|
|